Lege Artis Medicinae

[Anticoagulant treatment in cerebrovascular diseases]

NAGY Zoltán1

NOVEMBER 30, 1994

Lege Artis Medicinae - 1994;4(01 KLSZ)

[The practice and indication of anticoagulation in the care of cerebrovascular patients is still controversial. It is hoped that improved diagnostic facilities, the extensive use of imaging techniques, more accurate assessment and monitoring of haemostasis, and the increasing number of multicentre studies will help us to better define the conditions for treatment. The use of anticoagulant therapy may be justified in stroke prevention, mainly to prevent cardioembolisation in cases where the probability of stroke is higher than 5%, and in cerebral venous thrombosis and deep vein thrombosis. The use of anticoagulation in the treatment of progressive ischaemic stroke is still controversial. The experience with heparin (coumarins, warfarin) has been well established, whereas there is currently a lack of data and extensive clinical trials on the use of low molecular weight heparins, heparinoids. ]

AFFILIATIONS

  1. Agyérbetegségek Országos Központja Országos Pszichiátriai és Neurológiai Intézet Budapest

COMMENTS

0 comments

Further articles in this publication

Lege Artis Medicinae

[Introduction]

FENYVESI Tamás

[This LAM supplement was prompted by a very topical issue. Antithrombotic therapy has come to the forefront of the treatment of cardiovascular patients. Prolonged anticoagulant therapy involves mainly the use of coumarin derivatives, and platelet aggregation inhibition involves the extensive use of acetylsalicylic acid. The topicality of this issue can be approached from two angles. First, the incidence of ischaemic heart disease and cerebrovascular disease in the developed world is alarmingly high.]

Lege Artis Medicinae

[Antithrombotic therapy in cardiogenic thromboembolism]

LENGYEL Mária

[All 3 methods of antithrombotic therapy have a role in the primary and secondary prevention of cardiogenic thromboembolism. The most important modality is anticoagulant treatment which is indicated now in the majority of cases of nonvalvular atrial fibrillation. An tiplatelet therapy is of limited value in cardiogenic thromboembolism. The expanded clinical use of both kinds of treatment depends on increased safety and unchanged efficacy which can be achieved by reduced dosage and the combination of the two therapeutic methods. Thrombolytic therapy, until recently, has been limited to the thromboembolic diseases of the right heart. Presently, thrombolysis is being more and more often used in the lifesaving treatment of left sided prosthetic valve thrombosis. ]

Lege Artis Medicinae

[The role of echocardiography in anticoagulant treatment]

TEMESVÁRI András

[Echocardiography is the method of choice to detect the cardiac source of embolism. Trans thoracic echocardiography is preferred for the diagnosis of left ventricular thrombus. Trans esophageal echocardiography is more sensitive than transthoracic echocardiography in the detection of possible sources of systemic emboli (41-65% versus 14–37%). Left atrial and appendage thrombus, spontaneous echocontrast, patent foramen ovale, atrial septum aneurysm, left atrial myxoma and prosthetic valve thrombus are more frequently demonstrated by transeso phageal echocardiography. Right atilai and ventricular thrombus, embolus in the pulmonary artery, patent foramen ovale and pulmonary hypertension should be examined in pulmonary embolism. ]

Lege Artis Medicinae

[Coumarin therapy]

PÉTERFY Miklós

[Coumarin oral anticoagulants are highly effective antithrombotic agents with relatively low risks of serious bleeding. Clinical uses and applications have evolved over the years. Recent changes include a, lower doses are used to treat most patients with thromboses, b, laboratory monitoring has been standardised thus intensities of anticoagulation are equivalent around the world, C, new indications for treatment have emerged from prospoective controlled clinical trials, for example profilaxis of embolic stroke in patients with chronic nonrheumatic atrial fibrillation. Coumarins inhibit the factors II, VII, IX, X and protein C and S. Traditionally the prothrombin time has been used to monitor the antithrombotic effects of the coumarins. The test is performed by the addition of a thromboplastin to recalcified plasma. The sensitivity of the thromboplastin to coumarin induced reduction in clotting factor activity is variable in the assay. Some thromboplastins are very sensitive, others are insensitive. Consequently, patients can receive different doses of coumarin depending on the thromboplastin used. To address this important clinical problem, the prothrombin time ratio is now modified by a factor (ISI) that reflects the „sensitivity" of the thromboplastin used and the result is termed International Normalised Ratio (INR). The main coumarin adverse effects (hae morrhage, teratogenicity and coumarin skin necroses and some special problems of coumarin therapy (diet, coumarin resistance, drug-drug interactions, the problem of over lapping heparin and coumarin, the problem of interval surgery) are also discussed.]

All articles in the issue

Related contents

Clinical Neuroscience

The applications of transcranial Doppler in ischemic stroke

FINNSDÓTTIR Herdis, SZEGEDI István, OLÁH László, CSIBA László

Background: This overview provides a summary of the applications of transcranial Doppler (TCD) in ischemic stroke. Results: A fast-track neurovascular ultrasound protocol has been developed for detecting occlusion or stenosis. The technique is more reliable in the carotid area than in the posterior circulation. By monitoring the pulsatility index the in­crea­sed intracranial pressure can be diagnosed. TIBI score was developed for grading residual flow. TCD has been shown to accurately predict complete or any recanalization. Regarding recanalization, TCD has a sensitivity of 92%, a specificity of 88%, a positive predictive value of 96%, a negative predictive value of 78% and an overall accuracy of 91%, respectively. Sonothrombolysis seemed to be a promising application but randomized controlled trials have shown that it does not improve clinical outcome. TCD examination can detect microembolic signals (MES) which are associated with an increased risk of stroke. Micro­em­boli were detected in symptomatic and asymptomatic carotid artery stenosis and during carotid endarterectomy. The number of microemboli can be decreased by antithrombotic therapy. Contrast en­chan­ced examination and Valsalva maneuver with continuous TCD monitoring can accurately screen for right-to-left shunt.

Clinical Neuroscience

[Relationships between COVID-19 disease, nutritional status, and dysphagia, particularly in stroke patients ]

KOVÁCS Andrea, SZABÓ Pál Tamás, FOLYOVICH András

[The new coronavirus, SARS-CoV-2, which causes the COVID-19 disease can lead to severe acute respiratory distress syndrome (ARDS). It poses a serious challenge to the health care system, especially intensive care. Neurological patients, usually of advanced age and with a myriad of comorbidities, are at particular risk through the impact of the new coronavirus on their condition and nutritional capacity. Stroke is a leader in morbidity and mortality data, with a focus on dysphagia and its complications due to COVID-19 disease and acute cerebrovascular accident. In the acute phase of stroke, 30-50% of patients suffer from dysphagia, which still shows a prevalence of 10% six months later. Dysphagia results in decreased or insufficient fluid and nutrient uptake, supp­lemented by inactivity, leading to malnutrition and sarcopenia, which worsens overall condition, outcome, and rehabilitation efficiency. Screening and early detection of swallowing disorders is a fundamental issue in order to develop a personalized and timely-initiated nutritional therapy strategy. Nutritional therapy plays a key role in frequent intensive care due to COVID-19 disease, where it increases the chances of recovery and reduces the length of stay in the intensive care unit and mortality. This is especially true in critically ill patients requiring prolonged ventilation. In COVID-19 diagnosed patients, screening for dysphagia, bedside assessment, and instrumental examination, followed by swallowing rehabilitation, are of paramount importance. Stroke can also be a complication of the COVID-19 infection. Care for cerebrovascular patients has also adapted to the pandemic, “triazination” has become systemic, and dysphagia screening for stroke patients and nutritional therapy adapted to it have also shed new light. ]

Lege Artis Medicinae

[The history of acute stroke care in Hungary ]

BERECZKI Dániel

[Stroke is one of the most frequent causes of death and the most important cause of permanent disability worldwide and also in Hungary. The Hungarian medical literature has mentioned this disease and has been giving recommendations for its treatment since 1690. Initially folk medicines, herbal preparations and phlebotomy were used as standard therapy. Later, cooling the head joined these methods. Pharmacy preparations emerged at the middle of the 19th century. From the middle of the 20th century, products of the pharmaceutical industry like blood flow enhancers and neuroprotective drugs were in the frontline of the acute care. Anti­hy­per­ten­sive, antithrombotic and lipid-lowering medications became part of stro­ke prevention. Imaging techniques – mainly computer tomography of the brain and ultrasound examination of the cervical large arteries – have radically changed the diagnostics of cerebrovascular diseases from the middle of the 1980s. Since the 1990s, diagnostic and therapeutic decisions are based on reliable evidence from good quality clinical trials. Since the beginning of the 21st century, reperfusion treatments (intravenous thrombolysis and mechanical thrombectomy) re­present the most effective emergency care. The current direction is the extension of the therapeutic time-window of reperfusion treatments based on sophisticated neruoimaging. This review provides a brief summary of the development of stroke care in the last three and a half centuries as reflected in the Hungarian medical literature. ]

Clinical Neuroscience

How does the use of antiplatelet and anticoagulants affect the success of mechanical thrombectomy in acute ischemic stroke cases?

ÇABALAR Murat , ŞENGEZE Nihat , EREN Alper , İNANÇ Yusuf , GİRAY Semih

In this study, we wanted to investigate the effect of antiplatelet and anticoagulant use on the success of mechanical thrombectomy in acute ischemic stroke cases. 174 patients who were brought to the Stroke Center of Gaziantep University Şahinbey Research and Practice Hospital between January 2018 and February 2019 due to acute ischemic stroke and who underwent mechanical thrombectomy were retrospectively analyzed. The demographic characteristics, antiplatelet/anticoagulant use before the stroke and mTICI (modified-Throm­bolysis-In-Cerebral-Infarction) scores used for reperfusion in mechanical thrombectomy were evaluated. The findings were analyzed statistically (p<0.05). The mean age was 63.3 ± 13.5 in 174 patients who underwent mechanical thrombectomy. 23/174 (13.2%) patients were using anticoagulant therapy (warfarin-OAC or new generation oral anticoagulant-NOAC) and 28/174 (16.1%) were using antiplatelet therapy. A history of atrial fibrillation (AF) was significantly higher in patients receiving anticoagulant therapy before acute ischemic stroke (p=0.001). Patients with a history of hyper tension (HT), diabetes mellitus (DM) and coronary artery disease (CAD) before acute ischemic stroke were receiving antiplatelet therapy in higher rates (respectively; p=0.003, p=0.037, p=0.005). Successful recanalization (mTICI ≥ 2b) was higher in patients with a history of anticoagulant use and who underwent mechanical thrombectomy (p=0.025). Our study showed that the use of anti­platelet or anticoagulants before mechanical thrombec­tomy may have an indirect positive effect on the success of the procedure.

Clinical Neuroscience

[Systemic thrombolysis and endovascular intervention in postpartum stroke]

BERECZKI Dániel Jr., NÉMETH Beatrix, MAY Zsolt, SZAKÁCS ZOLTÁN, GUBUCZ István, SZIKORA István, SZILÁGYI Géza

[Introduction - There are no previously published cases about intravenously applied recombinant tissue plasminogen activator in acute ischemic stroke during puerperium. Case presentation - We report a 40-year-old woman with postpartum acute ischemic stroke caused by multiple cervical artery dissections treated by systemic thrombolysis and endovascular intervention. Discussion - There are only limited data regarding thrombolytic treatment in acute stroke during pregnancy and puerperium. Current acute stroke treatment guidelines - while considering pregnancy as a relative exclusion criterion - do not deal with the postpartum state. Conclusion - As the condition is rare, randomized controlled trials are not feasible, therefore further reports on similar cases could eventually help us suggest guidelines or at least propose recommendations for the acute thrombolytic treatment of strokes occurring in pregnancy and puerperium.]